Gerhard Schluter

Title: Gerhard Schluter: Innovator in Pharmaceutical Chemistry

Introduction

Gerhard Schluter is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antihypertensive and antianginal medications. With a total of 2 patents, his work has had a meaningful impact on medical treatments.

Latest Patents

Schluter's latest patents include innovative formulations that enhance the effectiveness of existing medications. One of his patents focuses on dihydropyridine preparations containing β-blockers, which are crucial for managing hypertension and angina. This patent describes a combination that includes 0.1 to 10 parts by weight of an asymmetrical dihydropyridine, where R¹ and R⁵ can be methyl, hydroxymethyl, or cyano. Another significant patent involves basic formulations of quinolonecarboxylic acids, aimed at improving the parenteral administration of carboxylic acids, where X can be N, C–H, or C–F.

Career Highlights

Gerhard Schluter has built a successful career at Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to focus on innovative drug formulations that address critical health issues. His expertise in pharmaceutical chemistry has positioned him as a key player in the development of new therapeutic solutions.

Collaborations

Throughout his career, Schluter has collaborated with esteemed colleagues, including Arundev H Naik and Herbert Voege. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Gerhard Schluter's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments, benefiting patients worldwide.